Objective
=========

To analyze the mortality of ventilator-asociated pneumonia (VAP) produced for a potential multiresistant microorganism (PMRM) according to antibiotic sensibility of the microorganisms responsible.

Methods
=======

It is a prospective study of patients admitted in the ICU from 1 May 2000 until 31 August 2002 and who developed VAP produced for a PMRM (*Staphylococcus aureus*, *Pseudomonas aeruginosa*, *Stenotrophomona maltofilia*, Acinetobacter). The statistical analysis was realized by chi-square test and Student *t* test, and we took values *P* \< 0.05 to consider a significant difference.

Results
=======

In the study period, 1389 patients were admitted. We documented 66 VAP for a PMRM. VAP mortality for MSSA versus MRSA was 27.77% (5/18) and 14.28% (2/14) (*P* = 0.35). VAP mortality for a Gram-negative bacilli PMRP was analyzed according to the sensitivity to four antibiotics (piperacillin--tazobactam, ceftazidime, imipenem and ciprofloxacin). VAP mortality for *P. aeruginosa* with 0--1 antibiotic resistances versus 2--4 antibiotic resistances was 2/22 (9.09%) and 2/4 (50%) (*P* = 0.03). VAP mortality for *S. maltofilia* with 0--2 antibiotic resistances versus 3--4 antibiotic resistances was 0/2 (0%) and 2/2 (100%) (*P* = 0.04). VAP mortality for Acinetobacter with 0 antibiotic resistances versus 1--4 antibiotic resistances was 0/2 (0%) and 1/2 (50%) (*P* = 0.24).

Conclusions
===========

In our series, the VAP mortality for *P. aeruginosa* and *S. maltofilia* was different according to antibiotic sensibility, but not when it was due to *S. aureus* and Acinetobacter.
